Translational research into sexual disorders: Pharmacology and genomics

European Journal of Pharmacology

Volumn 585, Issue 2-3, 2008, Pages 426-435

  Chan, Johnny S W ^a   Olivier, Berend ^a,c,d   de Jong, Trynke R ^a   Snoeren, Eelke M S ^a   Kooijman, Elke ^a   van Hasselt, Felisa N ^a   Limpens, Jules H W ^a   Kas, Martien J H ^a   Waldinger, Marcel D ^a,b   Oosting, Ronald S ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b University Medical Centre ^*  (Netherlands)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d PSYCHOGENICS INC   (United States)

Author keywords

Animal model; Dapoxetine; Endophenotype; Premature ejaculation; Serotonin; SSRI

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DAPOXETINE; FENFLURAMINE; FLUOXETINE; FLUVOXAMINE; GENOMIC DNA; MIRTAZAPINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEFAZODONE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

CHROMOSOME; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; EJACULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION;

ANIMALS; ANTIDEPRESSIVE AGENTS; EJACULATION; FEMALE; HUMANS; MALE; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SEXUAL BEHAVIOR, ANIMAL; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 43049138002     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.02.098     Document Type: Review

References (106)

1. Abdel-Hamid I.A., El Naggar E.A., and El Gilany A.H. Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int. J. Impot. Res. 13 (2001) 41-45
2. Ågmo A. Sexual motivation-an inquiry into events determining the occurrence of sexual behavior. Behav. Brain Res. 105 (1999) 129-150
3. 3 Antagonists and Benzodiazepines, Their Comparative Behavioral Pharmacology (1990), John Wiley and Sons, Chichester 281-315
4. 1B receptors in the inhibition of male rat ejaculatory behavior produced by 5-HTP. Psychopharmacology 137 (1998) 374-382
5. 1A antagonist WAY-100635 and citalopram on male rat ejaculatory behavior. Eur. J. Pharmacol. 379 (1999) 1-6
6. Ahlenius S., Larsson K., and Svensson L. Further evidence for an inhibitory role of central 5-HT in male rat sexual behavior. Psychopharmacology 68 (1980) 217-220
7. Albinsson A., Andersson G., Andersson K., Vega-Matuszczyk J., and Larsson K. The effects of lesions in the mesencephalic raphe systems on male rat sexual behavior and locomotor activity. Behav. Brain Res. 80 (1996) 57-63
8. Allard J., Truitt W.A., McKenna K.E., and Coolen L.M. Spinal cord control of ejaculation. World J. Urol. 23 (2005) 119-126
9. 2 antagonistic properties, on male-rat sexual-behavior. Eur. J. Pharmacol. 255 (1994) 131-137
10. Argiolas A. Neuropeptides and sexual behavior. Neurosci. Biobehav. Rev. 23 (1999) 1127-1142
11. Arletti R., Calza L., Giardino L., Benelli A., Cavazzuti E., and Bertolini A. Sexual impotence is associated with a reduced production of oxytocin and with an increased production of opioid peptides in the paraventricular nucleus of male rats. Neurosci. Lett. 233 (1997) 65-68
12. Aversa A., Bruzziches R., Pili M., and Spera G. Phosphodiesterase 5 inhibitors in the treatment of erectile dysfunction. Curr. Pharm. Des. 12 (2006) 3467-3484
13. Bago M., Marson L., and Dean C. Serotonergic projections to the rostroventrolateral medulla from midbrain and raphe nuclei. Brain Res. 945 (2002) 249-258
14. Barfield R.J., and Sachs B.D. Sexual behavior, stimulation by painful electrical shock to skin in male rats. Science 161 (1968) 392-395
15. Beach F.A. Comparison of copulatory behavior of male rats raised in isolation, cohabitation, and segregation. J. Genet. Psychol. 60 (1942) 3-13
16. Bitran D., and Hull E.M. Pharmacological analysis of male rat sexual behavior. Neurosci. Biobehav. Rev. 11 (1987) 365-389
17. Burns-Cusato M., Scordalakes E.M., and Rissman E.F. Of mice and missing data, what we know (and need to learn) about sexual behavior. Physiol. Behav. 83 (2004) 217-232
18. Cantor J., Binik I., and Pfaus J.G. Chronic fluoxetine inhibits sexual behavior in the male rat, reversal with oxytocin. Psychopharmacology 144 (1999) 355-362
19. Chia S.J. Management of premature ejaculation-a comparison of treatment outcome in patients with and without erectile dysfunction. Int. J. Androl. 25 (2002) 301-305
20. Clayton A.H. Extended-release bupropion, an antidepressant with a broad spectrum of therapeutic activity?. Expert Opin. Pharmacother. 8 (2007) 457-466
21. De Jong T.R., Pattij T., Veening J.G., Dederen P.J., Waldinger M.D., Cools A.R., and Olivier B. Citalopram combined with WAY100635 inhibits ejaculation and ejaculation-related Fos immunoreactivity. Eur. J. Pharmacol. 509 (2005) 49-59
22. De Jong T.R., Pattij T., Veening J.G., Waldinger M.D., Cools A.R., and Olivier B. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats, comparison of fluvoxamine and paroxetine. Psychopharmacology 179 (2005) 509-515
23. De Jong T.R., Veening J.G., Olivier B., and Waldinger M.D. Oxytocin involvement in SSRI-induced delayed ejaculation, a review of animal studies. J. Sex. Med. 4 (2007) 14-28
24. De Jong T.R., Veening J.G., Waldinger M.D., Cools A.R., and Olivier B. Serotonin and the neurobiology of the ejaculatory threshold. Neurosci. Biobehav. Rev. 30 (2006) 893-907
25. Dornan W.A., Katz J.L., and Ricaurte G.A. The effects of repeated administration of MDMA on the expression of sexual behavior in the male rat. Pharmacol. Biochem. Behav. 39 (1991) 813-816
26. Drago F., and Busa L. Acute low doses of melatonin restore full sexual activity in impotent male rats. Brain Res. 878 (2000) 98-104
27. Ellenbroek B.A., and Cools A.R. Apomorphine susceptibility and animal models for psychopathology, genes and environment. Behav. Genet. 32 (2002) 349-361
28. Ferrari F., and Giuliani D. The selective D-2 dopamine-receptor antagonist eticlopride counteracts the ejaculatio-praecox induced by the selective D-2-dopamine agonist SND-919 in the rat. Life Sci. 55 (1994) 1155-1162
29. Foley K.F., DeSanty K.P., and Kast R.E. Bupropion, pharmacology and therapeutic applications. Expert Rev. Neurother. 6 (2006) 1249-1265
30. Foreman M.M., Hall J.L., and Love R.L. Effects of fenfluramine and para-chloroamphetamine on sexual behavior of male rats. Psychopharmacology 107 (1992) 327-330
31. Frank J.L., Hendricks S.E., and Olson C.H. Multiple ejaculations and chronic fluoxetine, effects on male rat copulatory behavior. Pharmacol. Biochem. Behav. 66 (2000) 337-342
32. Gessa G.L., Paglietti E., and Pellegrini-Quarantotti B. Induction of copulatory behavior in sexual inactive rats by naloxone. Science 204 (1979) 203-205
33. Giuliani D., Ottani A., and Ferrari F. Influence of sildanefil on copulatory behavior in sluggish or normal ejaculator rats, a central dopamine mediated effect?. Neuropharmacology 42 (2002) 562-567
34. Giuliano F. Premature ejaculation. Definition and drug treatment (letter). Drugs 67 (2007) 1629-1630
35. Gonzales G., Mendoza L., Ruiz J., and Torrejon J. A demonstration that 5-hydroxytryptamine administered peripherally can affect sexual behavior in male rats. Life Sci. 31 (1982) 2775-2781
36. 1A receptors. J. Neurosci. 18 (1998) 10150-10156
37. Haensel S.M., and Slob A.K. Flesinoxan, a prosexual drug for male rats. Eur. J. Pharmacol. 330 (1997) 1-9
38. Haensel S.M., Mos J., Olivier B., and Slob A.K. Sex behavior of male and female Wistar rats affected by the serotonin agonist 8-OH-DPAT. Pharmacol. Biochem. Behav. 40 (1991) 221-228
39. Hermann G.E., Holmes G.M., Rogers R.C., Beattie M.S., and Bresnahan J.C. Descending projections from the rostral gigantocellular reticular nuclei complex. J. Comp. Neurol. 455 (2003) 210-221
40. 1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181. Br. J. Pharmacol. 125 (1998) 1733-1743
41. Holstege G. Central nervous system control of ejaculation. World J. Urol. 23 (2005) 109-114
42. Homberg J., Van den Akker M., Raaso H.S., Wardeh G., Binnekade R., Scoffelmeer A.N.M., and de Vries T.J. Enhanced motivation to self-administer cocaine is predicted by self-grooming behavior and relates to dopamine release in the rat medial prefrontal cortex and amygdala. Eur. J. Neurosci. 15 (2002) 1542-1550
43. Hoyer D., Clarke D.E., Fozard J.R., Hartic P.R., Martin G.R., Mylecharane E.J., Saxena P.R., and Humphrey P.P. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol. Rev. 46 (1994) 157-203
44. Hull E.M., Lorrain D.S., Du J., Matuszewich L., Lumley L.A., Putnam S.K., and Moses J. Hormone-neurotransmitter interactions in the control of sexual behavior. Behav. Brain Res. 105 (1999) 105-116
45. Hull E.M., Muschamp J.W., and Sato S. Dopamine and serotonin, influences on male sexual behavior. Physiol. Behav. 83 (2004) 291-307
46. Hull E.M., and Dominguez J.M. Sexual behavior in male rodents. Horm. Behav. 52 (2007) 45-55
47. JAX® Mice Database, The Jackson Laboratory. http//jaxmice.jax.org.
48. Johnson R.D., and Hubscher C.H. Brainstem microstimulation differentially inhibits pudendal motoneuron reflex inputs. NeuroReport 9 (1998) 341-345
49. 2 antagonist by attenuating DOI-induced inhibition of male rat sexual behavior. Psychopharmacology 119 (1995) 291-294
50. 2 receptor antagonist amperozide attenuates 1-(2, 5-dimethoxy-4-iodophenyl)-2-aminopropane-induced inhibition of male rat sexual behavior. Eur. J. Pharmacol. 212 (1992) 241-246
51. Krüger T.H.C., Hartmann U., and Schedlowski M. Prolactinergic and dopaminergic mechanisms underlying sexual arousal and orgasm in humans. World J. Urol. 23 (2005) 130-138
52. Larsson K., and Ahlenius S. Brain and sexual behavior. Ann. N.Y. Acad. Sci. 877 (1999) 292-308
53. Leyton M., and Stewart J. Acute and repeated activation of male sexual behavior by tail pinch, opioid and dopaminergic mechanisms. Physiol. Behav. 60 (1996) 77-85
54. 1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 39 (2000) 110-122
55. 1A receptors. J. Pharmacol. Exp. Ther. 282 (1997) 1581-1590
56. 1A receptor agonist. J. Pharmacol. Exp. Ther. 279 (1996) 1035-1042
57. Lobo R.A., Rosen R.C., Yang H.M., Block B., and Van der Hoop R.G. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil. Steril. 79 (2003) 1341-1352
58. Matuszcyk J.V., Larsson K., and Eriksson E. The selective serotonin reuptake inhibitor fluoxetine reduces sexual motivation in male rats. Pharmacol. Biochem. Behav. 60 (1998) 527-532
59. 1A antagonist. Brain Res. 820 (1999) 55-62
60. McMahon C.G., and Touma K. Treatment of premature ejaculation with paroxetine hydrochloride. Int. J. Impot. Res. 11 (1999) 241-245
61. Melis M.R., and Argiolas A. Dopamine and sexual behavior. Neurosci. Biobehav. Rev. 19 (1995) 19-38
62. Mos J., Olivier B., Bloetjes K., and Poth M. Drug-induced facilitation of sexual behavior in the male rat, behavioral and pharmacological aspects. In: Slob A.K., and Baum M.J. (Eds). Psychoneuroendocrinology of Growth and Development (1990), Medicom Publishers, Rotterdam, The Netherlands 221-232
63. Mos J., Van Logten J., Bloetjes K., and Olivier B. The effects of idazoxan and 8-OH-DPAT on sexual behavior and associated ultrasonic vocalizations in the rat. Neurosci. Biobehav. Rev. 15 (1991) 505-515
64. Mos J., Mollet I., Tolboom J.T., Waldinger M.D., and Olivier B. A comparison of the effects of different serotonin reuptake blockers on sexual behavior of the male rat. Eur. Neuropsychopharmacol. 9 (1999) 123-135
65. Mosig D.W., and Dewsbury D.A. Studies of the copulatory behavior of house mice (Mus musculus). Behav. Biol. 16 (1976) 463-473
66. Olivier B., van Oorschot R., and Waldinger M.D. Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behavior. Int. Clin. Psychopharmacol. 13 suppl 6 (1998) S9-S14
67. Olivier J.D., de Jong T.R., Jos Dederen P., van Oorschot R., Heeren D., Pattij T., Waldinger M.D., Coolen L.M., Cools A.R., Olivier B., and Veening J.G. Effects of acute and chronic apomorphine on sex behavior and copulation-induced neural activation in the male rat. Eur. J. Pharmacol. 8 576 (2007) 61-76
68. Ottani A., Giuliani D., and Ferrari F. Modulatory activity of sildanefil on copulatory behavior of both intact and castrated male rats. Pharmacol. Biochem. Behav. 72 (2002) 717-722
69. 1A receptor sensitivity, behavioral and functional correlates. Psychiatr. Genet. 6 (1996) 107-117
70. Pattij T., de Jong T.R., Uitterdijk A., Waldinger M.D., Veening J.G., Cools A.R., van der Graaf P.H., and Olivier B. Individual differences in male rat ejaculatory behavior, searching for models to study ejaculation disorders. Eur. J. Neurosci. 22 (2005) 724-734
71. Pfaus J.G. Neurobiology of sexual behavior. Curr. Opin. Neurobiol. 9 (1999) 751-758
72. Pfaus J.G., and Gorzalka B.B. Opioids and sexual behavior. Neurosci. Biobehav. Rev. 11 (1987) 1-34
73. Pfaus J.G., and Heeb M.M. Implications of immediate-early gene induction in the brain following sexual stimulation of female and male rodents. Brain Res. Bull. 44 (1997) 397-407
74. Pryor J.L., Althof S.E., Steidle C., Rosen R.C., Hellstrom W.J., Shabsigh R., Miloslavsky M., and Kell S. Dapoxetine Study Group. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation, an integrated analysis of two double-blind, randomised controlled trials. Lancet 368 (2006) 929-937
75. Rodriguez-Manzo G., Asai M., and Fernandez-Guasti A. Evidence for changes in brain enkephalin contents associated to male rat sexual activity. Behav. Brain Res. 131 (2002) 47-55
76. Rowland D.L., Cooper S.E., and Slob A.K. The treatment of premature ejaculation: psychological and biological strategies. Drugs Today (Barc) 34 10 (1998) 879-899
77. Singer J.B., Hill A.E., Burrage L.C., Olszens K.R., Song J., Justice M., O'Brien W.E., Conti D.V., Witte J.S., Lander E.S., and Nadeau J.H. Genetic dissection of complex traits with consomic strains of mice. Science. 304 5669 (2004) 445-448
78. Sluyter F., Van Oortmerssen G.A., De Ruiter A.J.H., and Koolhaas J.M. Aggression in wild house mice, current state of affairs. Behav. Genet. 26 (1996) 489-496
79. 1 autoreceptors, parallel purposes or pointless plurality?. Trends Neurosci. 23 (2000) 459-465
80. Swanson L.W., and Kuypers H.G. The paraventricular nucleus of the hypothalamus, cytoarchitectonic subdivisions and organization of projections to the pituitary, dorsal vagal complex, and spinal cord as demonstrated by retrograde fluorescence double-labeling methods. J. Comp. Neurol. 194 (1980) 555-570
81. Tagliamonte A., Tagliamonte P., Gessa G.L., and Brodie B.B. Compulsive sexual activity induced by p-chlorophenylalanine in normal and pinealectomized male rats. Science 166 (1969) 1433-1435
82. Truitt W.A., and Coolen L.M. Identification of a potential ejaculation generator in the spinal cord. Science 297 (2002) 1566-1569
83. Truitt W.A., Shipley M.T., Veening J.G., and Coolen L.M. Activation of a subset of lumbar spinothalamic neurons after copulatory behavior in male but not female rats. J. Neurosci. 23 (2003) 325-331
84. Veening J.G., and Coolen L.M. Neural activation following sexual behavior in the male and female rat brain. Behav. Brain Res. 92 (1998) 181-193
85. Waldinger M.D. The neurobiological approach to premature ejaculation (review). J. Urol. 168 (2002) 2359-2367
86. Waldinger M.D. Lifelong premature ejaculation, definition, serotonergic neurotransmission and drug treatment. World J. Urol. 23 (2005) 102-108
87. Waldinger M.D. Premature ejaculation, definition and drug treatment. Drugs 67 (2007) 547-568
88. Waldinger M.D. Premature ejaculation, state of the art. Urol. Clin. North Am.. 34 (2007) 591-599
89. Waldinger M.D. Premature ejaculation, different pathophysiologies and etiologies determine its treatment. J. Sex. Marital Ther. 34 (2008) 1-13
90. Waldinger M.D., and Olivier B. Selective serotonin reuptake inhibitor-induced sexual dysfunction, clinical and research considerations. Int. Clin. Psychopharmacol. 13 suppl 6 (1998) S27-S33
91. Waldinger M.D., and Schweitzer D.H. Retarded ejaculation in men, an overview of psychological and neurobiological insights. World J. Urol. 23 (2005) 76-81
92. Waldinger M.D., Hengeveld M.W., and Zwinderman A.H. Paroxetine treatment of premature ejaculation, a double-blind, randomized, placebo-controlled study. Am. J. Psychiatry. 151 (1994) 1377-1379
93. Waldinger M.D., Hengeveld M.W., Zwinderman A.H., and Olivier B. Effect of SSRI antidepressants on ejaculation, a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine and sertraline. J. Clin. Psychopharmacol. 18 (1998) 274-281
94. Waldinger M.D., Zwinderman A.H., and Olivier B. Antidepressants and ejaculation, a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone. J. Clin. Psychopharmacol. 21 (2001) 293-297
95. Waldinger M.D., Van de Plas A., Pattij T., Van Oorschot R., Coolen L.M., Veening J.G., and Olivier B. The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment. Psychopharmacology 160 (2002) 283-289
96. Waldinger M.D., Zwinderman A.H., and Olivier B. SSRIs and ejaculation, a double-blind, randomized, fixed-dose study with paroxetine and citalopram. J. Clin. Psychopharmacol. 21 (2003) 556-560
97. Waldinger M.D., Zwinderman A.H., and Olivier B. On-demand treatment of premature ejaculation with clomipramine and paroxetine, a randomized, double-blind fixed-dose study with stopwatch assessment. Eur. Urol. 46 (2004) 510-516
98. Waldinger M.D., Zwinderman A.H., Schweitzer D.H., and Olivier B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation, a systematic review and meta-analysis. Int. J. Impot. Res. 16 (2004) 369-381
99. Waldinger M.D., Schweitzer D.H., and Olivier B. On-demand SSRI treatment of premature ejaculation, pharmacodynamic limitations for relevant ejaculation delay and consequent solutions. J. Sex. Med. 2 (2005) 121-131
100. Waldinger M.D., Zwinderman A.H., Olivier B., and Schweitzer D.H. Proposal for a definition of lifelong premature ejaculation based on epidemiological stopwatch data. J. Sex. Med. 2 (2005) 498-507
101. Waldinger M.D., Quinn P., Dilleen M., Mundayat R., Schweitzer D.H., and Boolell M. A multinational population survey of intravaginal ejaculation latency time. J. Sex. Med. 2 (2005) 492-497
102. Waldinger M.D., Schweitzer D.H., and Olivier B. Dapoxetine treatment of premature ejaculation. Lancet. 368 (2006) 1869
103. Waldinger M.D., Zwinderman A.H., Olivier B., and Schweitzer D.H. Geometric mean intravaginal-ejaculation-latency-time and premature ejaculation, appropriate statistics to avoid overestimation of treatment efficacy. J. Sex. Medicine (2007) (Electronic publication)
104. Waldinger, M.D., Schweitzer, D.H., (in press). Premature ejaculation and pharmaceutical company-based medicine, The Dapoxetine case. J. Sex. Medicine.
105. Wang L., and Hull E.M. Tail pinch induces sexual behavior in olfactory bulbectomized male rats. Physiol. Behav. 24 (1980) 211-215
106. 2 antagonists. Pharmacol. Biochem. Behav. 39 (1991) 605-621